Ads
related to: bristol-myers Squibb- Savings Card
See If You Are Eligible To Save
On An ELIQUIS Prescription
- Chat With Elise
Get Help From Our
Virtual Assistant, Elise
- ELIQUIS & Safety Info
See Full Safety Info &
Boxed Warning. Learn More
- Prescribing Info
See Full Prescribing Info
Including Boxed Warning
- ELIQUIS HCP Info
Visit the Official US Healthcare
Website for ELIQUIS Safety Info
- Doctor Discussion Guide
Learn More About The Interactive
Eliquis Doctor Discussion Guide
- Savings Card
Search results
Bristol Myers, Sanofi liability in Hawaii Plavix case grows to $916 million
Reuters· 1 day ago, opens new tab to pay more than $916 million to the state for failing to warn non-white patients of...
1 Stock I Wouldn't Touch With a 10-Foot Pole
The Motley Fool via AOL· 3 days agoThere are many positive things about Bristol Myers Squibb (NYSE: BMY) and its stock. It has a decently high dividend yield, it's one of the world's largest pharmaceutical companies, and it makes ...
Taye Diggs Hopes Love Will ‘Magically’ Appear Post-Apryl Jones Split
US Weekly· 1 day agoTaye Diggs is still navigating how to approach his dating life. “I have no idea what I’m doing,”...
Hawaii wins $916M award from drugmaker
The Honolulu Star-Advertiser via Yahoo News· 1 day agoMay 22—1/1 Swipe or click to see more CINDY ELLEN RUSSELL / CRUSSELL@STARADVERTISER.COM Gov. Josh Green announced at a news conference Tuesday that the state was awarded $916 million from two ...
1 Stock I Wouldn't Touch With a 10-Foot Pole | The Motley Fool
The Motley Fool· 3 days agoThere are many positive things about Bristol Myers Squibb (BMY -2.51%) and its stock. It won't be...
At 44, Mindy Kaling Shares Her Diet and Fitness Routine Amid Weight Loss
Prevention via AOL· 3 days agoMindy Kaling Shares Her Favorite WorkoutSantiago Felipe - Getty Images Mindy Kaling opens up about...
Regeneron faces new biosimilar threats; an AI biotech lays off staff
BioPharma Dive via Yahoo Finance· 2 days agoBioPharma Dive is testing out a new format rounding up smaller updates from around the industry....
AbbVie Is 'Successfully Positioned To Absorb Humira Biosimilar Erosion': Analyst - AbbVie...
Benzinga· 6 days agoCantor Fitzgerald initiates coverage on AbbVie with an Overweight rating and a $200 price target....
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 2 days agoNeoPhore closes oversubscribed Series B extension round with additional funding from Bristol Myers Squibb PR Newswire LONDON, May 22, 2024 Additional funding will be used to explore novel biology around the MMR pathway and accelerate progression
This Unpopular Dividend Stock Is a Buy | The Motley Fool
The Motley Fool· 14 hours agoDividend stocks are an important anchor for well-balanced portfolios. Regular cash distributions can buffer a portfolio against market volatility and provide a steady income across business ...
